VIDEO: AI’s role in geographic atrophy treatment continues to grow

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Sharon Bakalash, MD, PhD, CBA, of Astellas Ophthalmics, discusses the company’s pipeline for geographic atrophy as well as AI’s growing role in treating the condition.

At the meeting, Astellas organized a panel of ophthalmic companies to discuss how AI can be utilized to benefit geographic atrophy research.

“We are doing this as a pharma company because we felt that there is a need to collate the whole community to find the solutions for this disease,” Bakalash said.

She also highlighted Astellas’ plans for the global launch of Izervay (avacincaptad pegol intravitreal solution).

Published by:

Sources/Disclosures

Collapse

Source:

Healio Interviews

Disclosures:
Bakalash reports being global medical affairs head for Astellas Ophthalmics.

Read more about

This post was originally published on this site